Global Biologic Medication in COVID-19 Market Size, Status and Forecast 2020-2026
According to China's clinical trials of COVID-19 treatment, the number of chemical drugs accounted for the highest proportion, followed by biological drugs, cell therapy, vaccines, and traditional Chinese medicine. Among the biological drugs, IL-6 related monoclonal antibodies (anti-inflammatory) account for the largest proportion, including tocilizumab and Sarilumab. This report focuses on the investigation and analysis of biologic medication and predicts the future market development of biopharmaceuticals under the influence of COVID-19. Biological drugs are mainly divided into two categories: neutralizing antibodies and anti-inflammatory drugs. The main subdivisions include: IL-6, C5a, CD147, PD-1 and Interferon (beta-1a), etc.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologic Medication in COVID-19 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biologic Medication in COVID-19 industry.
Based on our recent survey, we have several different scenarios about the Biologic Medication in COVID-19 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biologic Medication in COVID-19 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologic Medication in COVID-19 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologic Medication in COVID-19 market in terms of revenue.
Players, stakeholders, and other participants in the global Biologic Medication in COVID-19 market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biologic Medication in COVID-19 market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biologic Medication in COVID-19 market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologic Medication in COVID-19 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologic Medication in COVID-19 market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologic Medication in COVID-19 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biologic Medication in COVID-19 industry.
Based on our recent survey, we have several different scenarios about the Biologic Medication in COVID-19 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biologic Medication in COVID-19 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologic Medication in COVID-19 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologic Medication in COVID-19 market in terms of revenue.
Players, stakeholders, and other participants in the global Biologic Medication in COVID-19 market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biologic Medication in COVID-19 market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biologic Medication in COVID-19 market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologic Medication in COVID-19 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologic Medication in COVID-19 market.
The following players are covered in this report:
- Roche
- Sanofi
- Novartis
- Merck
- Bayer
- Shutaishen
- Biogen
- Regeneron Pharmaceuticals
- Vir Biotech
- Junshi Biosciences
- Anke Biotechnology
- OncoImmune
- Neutralizing Antibodies
- Anti-inflammatory Drugs
- COVID-19
- Influenza
- Malaria
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biologic Medication in COVID-19 Revenue
1.4 Market Analysis by Type
1.4.1 Global Biologic Medication in COVID-19 Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Neutralizing Antibodies
1.4.3 Anti-inflammatory Drugs
1.5 Market by Application
1.5.1 Global Biologic Medication in COVID-19 Market Share by Application: 2020 VS 2026
1.5.2 COVID-19
1.5.3 Influenza
1.5.4 Malaria
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Biologic Medication in COVID-19 Industry Impact
1.6.1 How the Covid-19 is Affecting the Biologic Medication in COVID-19 Industry
1.6.1.1 Biologic Medication in COVID-19 Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biologic Medication in COVID-19 Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biologic Medication in COVID-19 Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Biologic Medication in COVID-19 Market Perspective (2015-2026)
2.2 Biologic Medication in COVID-19 Growth Trends by Regions
2.2.1 Biologic Medication in COVID-19 Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biologic Medication in COVID-19 Historic Market Share by Regions (2015-2020)
2.2.3 Biologic Medication in COVID-19 Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biologic Medication in COVID-19 Market Growth Strategy
2.3.6 Primary Interviews with Key Biologic Medication in COVID-19 Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Biologic Medication in COVID-19 Players by Market Size
3.1.1 Global Top Biologic Medication in COVID-19 Players by Revenue (2015-2020)
3.1.2 Global Biologic Medication in COVID-19 Revenue Market Share by Players (2015-2020)
3.1.3 Global Biologic Medication in COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biologic Medication in COVID-19 Market Concentration Ratio
3.2.1 Global Biologic Medication in COVID-19 Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biologic Medication in COVID-19 Revenue in 2019
3.3 Biologic Medication in COVID-19 Key Players Head office and Area Served
3.4 Key Players Biologic Medication in COVID-19 Product Solution and Service
3.5 Date of Enter into Biologic Medication in COVID-19 Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Biologic Medication in COVID-19 Historic Market Size by Type (2015-2020)
4.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Type (2021-2026)
5 BIOLOGIC MEDICATION IN COVID-19 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Biologic Medication in COVID-19 Market Size by Application (2015-2020)
5.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Biologic Medication in COVID-19 Market Size (2015-2020)
6.2 Biologic Medication in COVID-19 Key Players in North America (2019-2020)
6.3 North America Biologic Medication in COVID-19 Market Size by Type (2015-2020)
6.4 North America Biologic Medication in COVID-19 Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Biologic Medication in COVID-19 Market Size (2015-2020)
7.2 Biologic Medication in COVID-19 Key Players in Europe (2019-2020)
7.3 Europe Biologic Medication in COVID-19 Market Size by Type (2015-2020)
7.4 Europe Biologic Medication in COVID-19 Market Size by Application (2015-2020)
8 CHINA
8.1 China Biologic Medication in COVID-19 Market Size (2015-2020)
8.2 Biologic Medication in COVID-19 Key Players in China (2019-2020)
8.3 China Biologic Medication in COVID-19 Market Size by Type (2015-2020)
8.4 China Biologic Medication in COVID-19 Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Biologic Medication in COVID-19 Market Size (2015-2020)
9.2 Biologic Medication in COVID-19 Key Players in Japan (2019-2020)
9.3 Japan Biologic Medication in COVID-19 Market Size by Type (2015-2020)
9.4 Japan Biologic Medication in COVID-19 Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Biologic Medication in COVID-19 Market Size (2015-2020)
10.2 Biologic Medication in COVID-19 Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biologic Medication in COVID-19 Market Size by Type (2015-2020)
10.4 Southeast Asia Biologic Medication in COVID-19 Market Size by Application (2015-2020)
11 INDIA
11.1 India Biologic Medication in COVID-19 Market Size (2015-2020)
11.2 Biologic Medication in COVID-19 Key Players in India (2019-2020)
11.3 India Biologic Medication in COVID-19 Market Size by Type (2015-2020)
11.4 India Biologic Medication in COVID-19 Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Biologic Medication in COVID-19 Market Size (2015-2020)
12.2 Biologic Medication in COVID-19 Key Players in Central & South America (2019-2020)
12.3 Central & South America Biologic Medication in COVID-19 Market Size by Type (2015-2020)
12.4 Central & South America Biologic Medication in COVID-19 Market Size by Application (2015-2020)
13KEY PLAYERS PROFILES
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview and Its Total Revenue
13.1.3 Roche Biologic Medication in COVID-19 Introduction
13.1.4 Roche Revenue in Biologic Medication in COVID-19 Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Sanofi
13.2.1 Sanofi Company Details
13.2.2 Sanofi Business Overview and Its Total Revenue
13.2.3 Sanofi Biologic Medication in COVID-19 Introduction
13.2.4 Sanofi Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.2.5 Sanofi Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview and Its Total Revenue
13.3.3 Novartis Biologic Medication in COVID-19 Introduction
13.3.4 Novartis Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview and Its Total Revenue
13.4.3 Merck Biologic Medication in COVID-19 Introduction
13.4.4 Merck Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Bayer
13.5.1 Bayer Company Details
13.5.2 Bayer Business Overview and Its Total Revenue
13.5.3 Bayer Biologic Medication in COVID-19 Introduction
13.5.4 Bayer Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.5.5 Bayer Recent Development
13.6 Shutaishen
13.6.1 Shutaishen Company Details
13.6.2 Shutaishen Business Overview and Its Total Revenue
13.6.3 Shutaishen Biologic Medication in COVID-19 Introduction
13.6.4 Shutaishen Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.6.5 Shutaishen Recent Development
13.7 Biogen
13.7.1 Biogen Company Details
13.7.2 Biogen Business Overview and Its Total Revenue
13.7.3 Biogen Biologic Medication in COVID-19 Introduction
13.7.4 Biogen Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.7.5 Biogen Recent Development
13.8 Regeneron Pharmaceuticals
13.8.1 Regeneron Pharmaceuticals Company Details
13.8.2 Regeneron Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Introduction
13.8.4 Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.8.5 Regeneron Pharmaceuticals Recent Development
13.9 Vir Biotech
13.9.1 Vir Biotech Company Details
13.9.2 Vir Biotech Business Overview and Its Total Revenue
13.9.3 Vir Biotech Biologic Medication in COVID-19 Introduction
13.9.4 Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.9.5 Vir Biotech Recent Development
13.10 Junshi Biosciences
13.10.1 Junshi Biosciences Company Details
13.10.2 Junshi Biosciences Business Overview and Its Total Revenue
13.10.3 Junshi Biosciences Biologic Medication in COVID-19 Introduction
13.10.4 Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.10.5 Junshi Biosciences Recent Development
13.11 Anke Biotechnology
10.11.1 Anke Biotechnology Company Details
10.11.2 Anke Biotechnology Business Overview and Its Total Revenue
10.11.3 Anke Biotechnology Biologic Medication in COVID-19 Introduction
10.11.4 Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2015-2020)
10.11.5 Anke Biotechnology Recent Development
13.12 OncoImmune
10.12.1 OncoImmune Company Details
10.12.2 OncoImmune Business Overview and Its Total Revenue
10.12.3 OncoImmune Biologic Medication in COVID-19 Introduction
10.12.4 OncoImmune Revenue in Biologic Medication in COVID-19 Business (2015-2020)
10.12.5 OncoImmune Recent Development
14ANALYST'S VIEWPOINTS/CONCLUSIONS
15APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biologic Medication in COVID-19 Revenue
1.4 Market Analysis by Type
1.4.1 Global Biologic Medication in COVID-19 Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Neutralizing Antibodies
1.4.3 Anti-inflammatory Drugs
1.5 Market by Application
1.5.1 Global Biologic Medication in COVID-19 Market Share by Application: 2020 VS 2026
1.5.2 COVID-19
1.5.3 Influenza
1.5.4 Malaria
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Biologic Medication in COVID-19 Industry Impact
1.6.1 How the Covid-19 is Affecting the Biologic Medication in COVID-19 Industry
1.6.1.1 Biologic Medication in COVID-19 Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biologic Medication in COVID-19 Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biologic Medication in COVID-19 Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Biologic Medication in COVID-19 Market Perspective (2015-2026)
2.2 Biologic Medication in COVID-19 Growth Trends by Regions
2.2.1 Biologic Medication in COVID-19 Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biologic Medication in COVID-19 Historic Market Share by Regions (2015-2020)
2.2.3 Biologic Medication in COVID-19 Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biologic Medication in COVID-19 Market Growth Strategy
2.3.6 Primary Interviews with Key Biologic Medication in COVID-19 Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Biologic Medication in COVID-19 Players by Market Size
3.1.1 Global Top Biologic Medication in COVID-19 Players by Revenue (2015-2020)
3.1.2 Global Biologic Medication in COVID-19 Revenue Market Share by Players (2015-2020)
3.1.3 Global Biologic Medication in COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biologic Medication in COVID-19 Market Concentration Ratio
3.2.1 Global Biologic Medication in COVID-19 Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biologic Medication in COVID-19 Revenue in 2019
3.3 Biologic Medication in COVID-19 Key Players Head office and Area Served
3.4 Key Players Biologic Medication in COVID-19 Product Solution and Service
3.5 Date of Enter into Biologic Medication in COVID-19 Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Biologic Medication in COVID-19 Historic Market Size by Type (2015-2020)
4.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Type (2021-2026)
5 BIOLOGIC MEDICATION IN COVID-19 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Biologic Medication in COVID-19 Market Size by Application (2015-2020)
5.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Biologic Medication in COVID-19 Market Size (2015-2020)
6.2 Biologic Medication in COVID-19 Key Players in North America (2019-2020)
6.3 North America Biologic Medication in COVID-19 Market Size by Type (2015-2020)
6.4 North America Biologic Medication in COVID-19 Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Biologic Medication in COVID-19 Market Size (2015-2020)
7.2 Biologic Medication in COVID-19 Key Players in Europe (2019-2020)
7.3 Europe Biologic Medication in COVID-19 Market Size by Type (2015-2020)
7.4 Europe Biologic Medication in COVID-19 Market Size by Application (2015-2020)
8 CHINA
8.1 China Biologic Medication in COVID-19 Market Size (2015-2020)
8.2 Biologic Medication in COVID-19 Key Players in China (2019-2020)
8.3 China Biologic Medication in COVID-19 Market Size by Type (2015-2020)
8.4 China Biologic Medication in COVID-19 Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Biologic Medication in COVID-19 Market Size (2015-2020)
9.2 Biologic Medication in COVID-19 Key Players in Japan (2019-2020)
9.3 Japan Biologic Medication in COVID-19 Market Size by Type (2015-2020)
9.4 Japan Biologic Medication in COVID-19 Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Biologic Medication in COVID-19 Market Size (2015-2020)
10.2 Biologic Medication in COVID-19 Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biologic Medication in COVID-19 Market Size by Type (2015-2020)
10.4 Southeast Asia Biologic Medication in COVID-19 Market Size by Application (2015-2020)
11 INDIA
11.1 India Biologic Medication in COVID-19 Market Size (2015-2020)
11.2 Biologic Medication in COVID-19 Key Players in India (2019-2020)
11.3 India Biologic Medication in COVID-19 Market Size by Type (2015-2020)
11.4 India Biologic Medication in COVID-19 Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Biologic Medication in COVID-19 Market Size (2015-2020)
12.2 Biologic Medication in COVID-19 Key Players in Central & South America (2019-2020)
12.3 Central & South America Biologic Medication in COVID-19 Market Size by Type (2015-2020)
12.4 Central & South America Biologic Medication in COVID-19 Market Size by Application (2015-2020)
13KEY PLAYERS PROFILES
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview and Its Total Revenue
13.1.3 Roche Biologic Medication in COVID-19 Introduction
13.1.4 Roche Revenue in Biologic Medication in COVID-19 Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Sanofi
13.2.1 Sanofi Company Details
13.2.2 Sanofi Business Overview and Its Total Revenue
13.2.3 Sanofi Biologic Medication in COVID-19 Introduction
13.2.4 Sanofi Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.2.5 Sanofi Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview and Its Total Revenue
13.3.3 Novartis Biologic Medication in COVID-19 Introduction
13.3.4 Novartis Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview and Its Total Revenue
13.4.3 Merck Biologic Medication in COVID-19 Introduction
13.4.4 Merck Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Bayer
13.5.1 Bayer Company Details
13.5.2 Bayer Business Overview and Its Total Revenue
13.5.3 Bayer Biologic Medication in COVID-19 Introduction
13.5.4 Bayer Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.5.5 Bayer Recent Development
13.6 Shutaishen
13.6.1 Shutaishen Company Details
13.6.2 Shutaishen Business Overview and Its Total Revenue
13.6.3 Shutaishen Biologic Medication in COVID-19 Introduction
13.6.4 Shutaishen Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.6.5 Shutaishen Recent Development
13.7 Biogen
13.7.1 Biogen Company Details
13.7.2 Biogen Business Overview and Its Total Revenue
13.7.3 Biogen Biologic Medication in COVID-19 Introduction
13.7.4 Biogen Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.7.5 Biogen Recent Development
13.8 Regeneron Pharmaceuticals
13.8.1 Regeneron Pharmaceuticals Company Details
13.8.2 Regeneron Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Introduction
13.8.4 Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.8.5 Regeneron Pharmaceuticals Recent Development
13.9 Vir Biotech
13.9.1 Vir Biotech Company Details
13.9.2 Vir Biotech Business Overview and Its Total Revenue
13.9.3 Vir Biotech Biologic Medication in COVID-19 Introduction
13.9.4 Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.9.5 Vir Biotech Recent Development
13.10 Junshi Biosciences
13.10.1 Junshi Biosciences Company Details
13.10.2 Junshi Biosciences Business Overview and Its Total Revenue
13.10.3 Junshi Biosciences Biologic Medication in COVID-19 Introduction
13.10.4 Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2015-2020)
13.10.5 Junshi Biosciences Recent Development
13.11 Anke Biotechnology
10.11.1 Anke Biotechnology Company Details
10.11.2 Anke Biotechnology Business Overview and Its Total Revenue
10.11.3 Anke Biotechnology Biologic Medication in COVID-19 Introduction
10.11.4 Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2015-2020)
10.11.5 Anke Biotechnology Recent Development
13.12 OncoImmune
10.12.1 OncoImmune Company Details
10.12.2 OncoImmune Business Overview and Its Total Revenue
10.12.3 OncoImmune Biologic Medication in COVID-19 Introduction
10.12.4 OncoImmune Revenue in Biologic Medication in COVID-19 Business (2015-2020)
10.12.5 OncoImmune Recent Development
14ANALYST'S VIEWPOINTS/CONCLUSIONS
15APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Biologic Medication in COVID-19 Key Market Segments
Table 2. Key Players Covered: Ranking by Biologic Medication in COVID-19 Revenue
Table 3. Ranking of Global Top Biologic Medication in COVID-19 Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biologic Medication in COVID-19 Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Neutralizing Antibodies
Table 6. Key Players of Anti-inflammatory Drugs
Table 7. COVID-19 Impact Global Market: (Four Biologic Medication in COVID-19 Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Biologic Medication in COVID-19 Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Biologic Medication in COVID-19 Players to Combat Covid-19 Impact
Table 12. Global Biologic Medication in COVID-19 Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Biologic Medication in COVID-19 Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Biologic Medication in COVID-19 Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Biologic Medication in COVID-19 Market Share by Regions (2015-2020)
Table 16. Global Biologic Medication in COVID-19 Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Biologic Medication in COVID-19 Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Biologic Medication in COVID-19 Market Growth Strategy
Table 22. Main Points Interviewed from Key Biologic Medication in COVID-19 Players
Table 23. Global Biologic Medication in COVID-19 Revenue by Players (2015-2020) (Million US$)
Table 24. Global Biologic Medication in COVID-19 Market Share by Players (2015-2020)
Table 25. Global Top Biologic Medication in COVID-19 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Medication in COVID-19 as of 2019)
Table 26. Global Biologic Medication in COVID-19 by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Biologic Medication in COVID-19 Product Solution and Service
Table 29. Date of Enter into Biologic Medication in COVID-19 Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 32. Global Biologic Medication in COVID-19 Market Size Share by Type (2015-2020)
Table 33. Global Biologic Medication in COVID-19 Revenue Market Share by Type (2021-2026)
Table 34. Global Biologic Medication in COVID-19 Market Size Share by Application (2015-2020)
Table 35. Global Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 36. Global Biologic Medication in COVID-19 Market Size Share by Application (2021-2026)
Table 37. North America Key Players Biologic Medication in COVID-19 Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Biologic Medication in COVID-19 Market Share (2019-2020)
Table 39. North America Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 40. North America Biologic Medication in COVID-19 Market Share by Type (2015-2020)
Table 41. North America Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 42. North America Biologic Medication in COVID-19 Market Share by Application (2015-2020)
Table 43. Europe Key Players Biologic Medication in COVID-19 Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Biologic Medication in COVID-19 Market Share (2019-2020)
Table 45. Europe Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Biologic Medication in COVID-19 Market Share by Type (2015-2020)
Table 47. Europe Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Biologic Medication in COVID-19 Market Share by Application (2015-2020)
Table 49. China Key Players Biologic Medication in COVID-19 Revenue (2019-2020) (Million US$)
Table 50. China Key Players Biologic Medication in COVID-19 Market Share (2019-2020)
Table 51. China Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 52. China Biologic Medication in COVID-19 Market Share by Type (2015-2020)
Table 53. China Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 54. China Biologic Medication in COVID-19 Market Share by Application (2015-2020)
Table 55. Japan Key Players Biologic Medication in COVID-19 Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Biologic Medication in COVID-19 Market Share (2019-2020)
Table 57. Japan Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Biologic Medication in COVID-19 Market Share by Type (2015-2020)
Table 59. Japan Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Biologic Medication in COVID-19 Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Biologic Medication in COVID-19 Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Biologic Medication in COVID-19 Market Share (2019-2020)
Table 63. Southeast Asia Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Biologic Medication in COVID-19 Market Share by Type (2015-2020)
Table 65. Southeast Asia Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Biologic Medication in COVID-19 Market Share by Application (2015-2020)
Table 67. India Key Players Biologic Medication in COVID-19 Revenue (2019-2020) (Million US$)
Table 68. India Key Players Biologic Medication in COVID-19 Market Share (2019-2020)
Table 69. India Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 70. India Biologic Medication in COVID-19 Market Share by Type (2015-2020)
Table 71. India Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 72. India Biologic Medication in COVID-19 Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Biologic Medication in COVID-19 Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Biologic Medication in COVID-19 Market Share (2019-2020)
Table 75. Central & South America Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Biologic Medication in COVID-19 Market Share by Type (2015-2020)
Table 77. Central & South America Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Biologic Medication in COVID-19 Market Share by Application (2015-2020)
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi Product
Table 87. Sanofi Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 88. Sanofi Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Product
Table 92. Novartis Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 93. Novartis Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Product
Table 97. Merck Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 98. Merck Recent Development
Table 99. Bayer Company Details
Table 100. Bayer Business Overview
Table 101. Bayer Product
Table 102. Bayer Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 103. Bayer Recent Development
Table 104. Shutaishen Company Details
Table 105. Shutaishen Business Overview
Table 106. Shutaishen Product
Table 107. Shutaishen Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 108. Shutaishen Recent Development
Table 109. Biogen Company Details
Table 110. Biogen Business Overview
Table 111. Biogen Product
Table 112. Biogen Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 113. Biogen Recent Development
Table 114. Regeneron Pharmaceuticals Business Overview
Table 115. Regeneron Pharmaceuticals Product
Table 116. Regeneron Pharmaceuticals Company Details
Table 117. Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 118. Regeneron Pharmaceuticals Recent Development
Table 119. Vir Biotech Company Details
Table 120. Vir Biotech Business Overview
Table 121. Vir Biotech Product
Table 122. Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 123. Vir Biotech Recent Development
Table 124. Junshi Biosciences Company Details
Table 125. Junshi Biosciences Business Overview
Table 126. Junshi Biosciences Product
Table 127. Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 128. Junshi Biosciences Recent Development
Table 129. Anke Biotechnology Company Details
Table 130. Anke Biotechnology Business Overview
Table 131. Anke Biotechnology Product
Table 132. Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 133. Anke Biotechnology Recent Development
Table 134. OncoImmune Company Details
Table 135. OncoImmune Business Overview
Table 136. OncoImmune Product
Table 137. OncoImmune Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 138. OncoImmune Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 1. Biologic Medication in COVID-19 Key Market Segments
Table 2. Key Players Covered: Ranking by Biologic Medication in COVID-19 Revenue
Table 3. Ranking of Global Top Biologic Medication in COVID-19 Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biologic Medication in COVID-19 Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Neutralizing Antibodies
Table 6. Key Players of Anti-inflammatory Drugs
Table 7. COVID-19 Impact Global Market: (Four Biologic Medication in COVID-19 Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Biologic Medication in COVID-19 Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Biologic Medication in COVID-19 Players to Combat Covid-19 Impact
Table 12. Global Biologic Medication in COVID-19 Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Biologic Medication in COVID-19 Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Biologic Medication in COVID-19 Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Biologic Medication in COVID-19 Market Share by Regions (2015-2020)
Table 16. Global Biologic Medication in COVID-19 Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Biologic Medication in COVID-19 Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Biologic Medication in COVID-19 Market Growth Strategy
Table 22. Main Points Interviewed from Key Biologic Medication in COVID-19 Players
Table 23. Global Biologic Medication in COVID-19 Revenue by Players (2015-2020) (Million US$)
Table 24. Global Biologic Medication in COVID-19 Market Share by Players (2015-2020)
Table 25. Global Top Biologic Medication in COVID-19 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Medication in COVID-19 as of 2019)
Table 26. Global Biologic Medication in COVID-19 by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Biologic Medication in COVID-19 Product Solution and Service
Table 29. Date of Enter into Biologic Medication in COVID-19 Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 32. Global Biologic Medication in COVID-19 Market Size Share by Type (2015-2020)
Table 33. Global Biologic Medication in COVID-19 Revenue Market Share by Type (2021-2026)
Table 34. Global Biologic Medication in COVID-19 Market Size Share by Application (2015-2020)
Table 35. Global Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 36. Global Biologic Medication in COVID-19 Market Size Share by Application (2021-2026)
Table 37. North America Key Players Biologic Medication in COVID-19 Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Biologic Medication in COVID-19 Market Share (2019-2020)
Table 39. North America Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 40. North America Biologic Medication in COVID-19 Market Share by Type (2015-2020)
Table 41. North America Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 42. North America Biologic Medication in COVID-19 Market Share by Application (2015-2020)
Table 43. Europe Key Players Biologic Medication in COVID-19 Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Biologic Medication in COVID-19 Market Share (2019-2020)
Table 45. Europe Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Biologic Medication in COVID-19 Market Share by Type (2015-2020)
Table 47. Europe Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Biologic Medication in COVID-19 Market Share by Application (2015-2020)
Table 49. China Key Players Biologic Medication in COVID-19 Revenue (2019-2020) (Million US$)
Table 50. China Key Players Biologic Medication in COVID-19 Market Share (2019-2020)
Table 51. China Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 52. China Biologic Medication in COVID-19 Market Share by Type (2015-2020)
Table 53. China Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 54. China Biologic Medication in COVID-19 Market Share by Application (2015-2020)
Table 55. Japan Key Players Biologic Medication in COVID-19 Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Biologic Medication in COVID-19 Market Share (2019-2020)
Table 57. Japan Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Biologic Medication in COVID-19 Market Share by Type (2015-2020)
Table 59. Japan Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Biologic Medication in COVID-19 Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Biologic Medication in COVID-19 Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Biologic Medication in COVID-19 Market Share (2019-2020)
Table 63. Southeast Asia Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Biologic Medication in COVID-19 Market Share by Type (2015-2020)
Table 65. Southeast Asia Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Biologic Medication in COVID-19 Market Share by Application (2015-2020)
Table 67. India Key Players Biologic Medication in COVID-19 Revenue (2019-2020) (Million US$)
Table 68. India Key Players Biologic Medication in COVID-19 Market Share (2019-2020)
Table 69. India Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 70. India Biologic Medication in COVID-19 Market Share by Type (2015-2020)
Table 71. India Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 72. India Biologic Medication in COVID-19 Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Biologic Medication in COVID-19 Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Biologic Medication in COVID-19 Market Share (2019-2020)
Table 75. Central & South America Biologic Medication in COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Biologic Medication in COVID-19 Market Share by Type (2015-2020)
Table 77. Central & South America Biologic Medication in COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Biologic Medication in COVID-19 Market Share by Application (2015-2020)
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi Product
Table 87. Sanofi Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 88. Sanofi Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Product
Table 92. Novartis Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 93. Novartis Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Product
Table 97. Merck Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 98. Merck Recent Development
Table 99. Bayer Company Details
Table 100. Bayer Business Overview
Table 101. Bayer Product
Table 102. Bayer Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 103. Bayer Recent Development
Table 104. Shutaishen Company Details
Table 105. Shutaishen Business Overview
Table 106. Shutaishen Product
Table 107. Shutaishen Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 108. Shutaishen Recent Development
Table 109. Biogen Company Details
Table 110. Biogen Business Overview
Table 111. Biogen Product
Table 112. Biogen Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 113. Biogen Recent Development
Table 114. Regeneron Pharmaceuticals Business Overview
Table 115. Regeneron Pharmaceuticals Product
Table 116. Regeneron Pharmaceuticals Company Details
Table 117. Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 118. Regeneron Pharmaceuticals Recent Development
Table 119. Vir Biotech Company Details
Table 120. Vir Biotech Business Overview
Table 121. Vir Biotech Product
Table 122. Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 123. Vir Biotech Recent Development
Table 124. Junshi Biosciences Company Details
Table 125. Junshi Biosciences Business Overview
Table 126. Junshi Biosciences Product
Table 127. Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 128. Junshi Biosciences Recent Development
Table 129. Anke Biotechnology Company Details
Table 130. Anke Biotechnology Business Overview
Table 131. Anke Biotechnology Product
Table 132. Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 133. Anke Biotechnology Recent Development
Table 134. OncoImmune Company Details
Table 135. OncoImmune Business Overview
Table 136. OncoImmune Product
Table 137. OncoImmune Revenue in Biologic Medication in COVID-19 Business (2015-2020) (Million US$)
Table 138. OncoImmune Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Biologic Medication in COVID-19 Market Share by Type: 2020 VS 2026
Figure 2. Neutralizing Antibodies Features
Figure 3. Anti-inflammatory Drugs Features
Figure 4. Global Biologic Medication in COVID-19 Market Share by Application: 2020 VS 2026
Figure 5. COVID-19 Case Studies
Figure 6. Influenza Case Studies
Figure 7. Malaria Case Studies
Figure 8. Others Case Studies
Figure 9. Biologic Medication in COVID-19 Report Years Considered
Figure 10. Global Biologic Medication in COVID-19 Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Biologic Medication in COVID-19 Market Share by Regions: 2020 VS 2026
Figure 12. Global Biologic Medication in COVID-19 Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Biologic Medication in COVID-19 Market Share by Players in 2019
Figure 15. Global Top Biologic Medication in COVID-19 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Medication in COVID-19 as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Biologic Medication in COVID-19 Revenue in 2019
Figure 17. North America Biologic Medication in COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Biologic Medication in COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Biologic Medication in COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Biologic Medication in COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Biologic Medication in COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Biologic Medication in COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Biologic Medication in COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Roche Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 26. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Sanofi Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 28. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Novartis Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 30. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Merck Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 32. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Bayer Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 34. Shutaishen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Shutaishen Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 36. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Biogen Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 38. Regeneron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Regeneron Pharmaceuticals Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 40. Vir Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Vir Biotech Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 42. Junshi Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Junshi Biosciences Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 44. Anke Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Anke Biotechnology Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 46. OncoImmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. OncoImmune Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Figure 1. Global Biologic Medication in COVID-19 Market Share by Type: 2020 VS 2026
Figure 2. Neutralizing Antibodies Features
Figure 3. Anti-inflammatory Drugs Features
Figure 4. Global Biologic Medication in COVID-19 Market Share by Application: 2020 VS 2026
Figure 5. COVID-19 Case Studies
Figure 6. Influenza Case Studies
Figure 7. Malaria Case Studies
Figure 8. Others Case Studies
Figure 9. Biologic Medication in COVID-19 Report Years Considered
Figure 10. Global Biologic Medication in COVID-19 Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Biologic Medication in COVID-19 Market Share by Regions: 2020 VS 2026
Figure 12. Global Biologic Medication in COVID-19 Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Biologic Medication in COVID-19 Market Share by Players in 2019
Figure 15. Global Top Biologic Medication in COVID-19 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Medication in COVID-19 as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Biologic Medication in COVID-19 Revenue in 2019
Figure 17. North America Biologic Medication in COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Biologic Medication in COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Biologic Medication in COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Biologic Medication in COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Biologic Medication in COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Biologic Medication in COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Biologic Medication in COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Roche Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 26. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Sanofi Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 28. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Novartis Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 30. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Merck Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 32. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Bayer Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 34. Shutaishen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Shutaishen Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 36. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Biogen Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 38. Regeneron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Regeneron Pharmaceuticals Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 40. Vir Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Vir Biotech Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 42. Junshi Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Junshi Biosciences Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 44. Anke Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Anke Biotechnology Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 46. OncoImmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. OncoImmune Revenue Growth Rate in Biologic Medication in COVID-19 Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
